Belluscura plc

Belluscura has developed the X-PLOR, a lightweight, portable oxygen delivery device aimed at treating the millions of people globally suffering from chronic lung diseases. The company plans to launch this novel and cost-effective device in the US in 2019, with Europe to follow.

Amount raised (£)

£538,140
Company number

09910883
Incorporation date

10/12/2015
Total investors

302

News

View all news

Tekcapital investee Belluscura eyes raising GBP17.5 million in AIM IPO Morning Star	21/05/2021
Intention to float - AIM London Stock Exchange	07/05/2021
Medical device firm Belluscura has revealed plans for a London float CityAM	16/11/2017
Belluscur plans London float CityAM	16/11/2017
Acquisition for medical device company Insider Media	27/04/2017

Online presence

Details

Company number
09910883
Incorporation date
10/12/2015
Company status
Active
Industry type
Manufacture of consumer electronics
Number of current appointments
7

Location

View on Google Maps

15 Fetter Lane
London
EC4A 1BW

Crowdcube Funding History

Date	Amount	No. of Investors
23/04/2019	£538,140	302	View

Key Financials

View all financials

	2019	2020
Turnover	£90.98k	£0
Cash	£730.6k	£367.64k
Increase in Cash	£331.94k	£-376.28k

Financial data drawn from last filed accounts don't necessarily reflect current trading activity.

Documents

Date	Description	Type
08/06/2022	Statement of capital following an allotment of shares on 2022-05-19	PDF
08/06/2022	Notification of a person with significant control statement	PDF
08/06/2022	Statement of capital following an allotment of shares on 2022-05-18	PDF

People

Name	Role	Appointed	Nationality
DYER, Anthony Stephen	Secretary	17/11/2017	British
DYER, Anthony Stephen	Director	17/11/2017	British
PIPER, Richard John	Director	21/05/2021	British
POUTNEY, David John	Director	21/05/2021	British
RAUKER, Robert	Director	16/08/2016	American
REYNOLDS, Adam	Director	21/04/2021	British
STROLLO, Patrick	Director	21/04/2021	American

£538,140

09910883

10/12/2015

302